Skip to main content

We make finding a doctor in the UAE free, transparent, and easy.

Back to Intelligence
XTransfer gets 2026 CBUAE payment approval, raising clinic payment options

XTransfer gets 2026 CBUAE payment approval, raising clinic payment options

XTransfer has CBUAE in-principle approval for a UAE retail payment services licence. Clinics should review payment costs, settlements and insurer workflows.

Zavis Intelligence·Healthcare Industry Desk
6 Sept 2026·3 min read

How Zavis verifies this coverage

Editorial standards, source rules, methodology, and review provenance are public.

XTransfer said on 3 September 2026 that it has secured in-principle approval from the Central Bank of the UAE (CBUAE) for a Retail Payment Services Licence, a step that could add another regulated option for UAE healthcare operators handling cross-border payments and merchant collections.

For Dubai clinics, the immediate issue is procurement discipline. A CBUAE in-principle approval is not the same as a final licence. XTransfer said the licence would become effective after it completes pre-issuance conditions. CFOs and COOs should treat the announcement as a vendor watch-list item, not a mandate to switch payment processors in 2026.

What CBUAE approval changes

The XTransfer announcement, carried by The Manila Times through GlobeNewswire, says the licence would allow XTransfer to serve mainland UAE clients once pre-issuance conditions are met. The company describes its product as regulated B2B payment services for international trade. That matters for healthcare groups paying overseas labs, device distributors, locum agencies, software vendors or regional suppliers.

The CBUAE's Retail Payment Services and Card Schemes Regulation sits under Circular No. 15/2021. The framework covers activities such as payment account services, merchant acquiring, domestic fund transfers and cross-border fund transfers. Third-party summaries of the rulebook place licence categories across Category I to Category IV, with capital requirements ranging from about AED 100,000 for limited payment initiation or account information services to about AED 3 million for higher-volume Category I activity.

Healthcare operators should ask any payment vendor for three documents before onboarding: the final CBUAE licence or approval letter, the exact licensed service category, and written confirmation on whether client funds are held, safeguarded or routed through a bank partner. The answer affects treasury risk, data handling and reconciliation inside clinic finance systems.

Why clinics, insurers and patients should care

Dubai is the first market to watch because Dubai Health Authority (DHA) licensing, mandatory health insurance and private clinic density make payment operations visible to patients and insurers. Abu Dhabi providers must map the same issue against Department of Health Abu Dhabi (DOH) rules and payer workflows involving Daman and Thiqa. In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, operators should also check Ministry of Health and Prevention (MOHAP) requirements and the federal private-sector insurance rollout that started on 1 January 2025.

The impact is practical. A clinic that collects co-payments, deductibles and self-pay balances across card terminals, payment links and online booking pages needs predictable settlement. A new regulated payment provider can help only if it reduces failed collections, shortens settlement time or lowers merchant charges. In the UAE, published processor pricing varies by acquirer, card type, channel and volume; operators should request a written merchant service charge quote and compare it with their current effective rate, including gateway fees, chargeback fees, refund fees and cross-border currency costs.

  • CFOs should compare total payment cost per AED 1,000 collected, not headline percentage rates.
  • COOs should test settlement reconciliation against clinic management software before adding a new payment channel.
  • CIOs should require API documentation, PCI DSS status, data residency terms and incident notification timelines.
  • CMOs should check whether payment links support Arabic and English patient journeys before using them in campaigns.

Due diligence before switching

XTransfer's approval is part of a wider move by payment firms into regulated UAE infrastructure. For clinics, the white space is less about novelty and more about execution. The payment layer touches patient registration, insurer pre-authorisation, claims recovery, receivables ageing and refunds. A missed settlement file can become a revenue-cycle problem within 30 days.

Medical directors also have a stake. Payment workflows can affect consent, refunds for cancelled procedures and documentation for elective services. Where a patient pays before insurer approval, the clinic should keep the payment record linked to the clinical episode and insurer decision. That is a governance issue for DHA in Dubai, DOH in Abu Dhabi and MOHAP-regulated facilities in the northern emirates.

The next checkpoint is whether XTransfer completes CBUAE's pre-issuance conditions and publishes the final scope of the UAE licence. Until then, healthcare groups should add XTransfer to their 2026 payment vendor review and benchmark it against licensed acquirers already connected to their bank, insurer and clinic systems. Patients comparing licensed clinics and providers can start with the UAE Open Healthcare Directory.

ZI

Zavis Intelligence

Healthcare Industry Desk

Contributing to UAE healthcare industry coverage

Source: The Manila Times

FAQ

What is happening in UAE healthcare industry?

XTransfer has CBUAE in-principle approval for a UAE retail payment services licence. Clinics should review payment costs, settlements and insurer workflows.